Clearstead Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107K | Sell |
305
-70
| -19% | -$25K | 0.02% | 239 |
|
|
2025
Q4 | $123K | Sell |
375
-177
| -32% | -$56.1K | 0.02% | 228 |
|
|
2025
Q3 | $156K | Sell |
552
-31
| -5% | -$8.99K | 0.03% | 204 |
|
|
2025
Q2 | $163K | Buy |
583
+313
| +116% | +$88.7K | 0.03% | 193 |
|
|
2025
Q1 | $84.1K | Sell |
270
-824
| -75% | -$243K | 0.02% | 222 |
|
|
2024
Q4 | $285K | Buy |
1,094
+130
| +13% | +$38.6K | 0.06% | 127 |
|
|
2024
Q3 | $311K | Sell |
964
-1
| -0.1% | -$327 | 0.07% | 106 |
|
|
2024
Q2 | $302K | Sell |
965
-275
| -22% | -$80.8K | 0.08% | 104 |
|
|
2024
Q1 | $353K | Hold |
1,240
| – | – | 0.09% | 94 |
|
|
2023
Q4 | $357K | Buy |
1,240
+700
| +130% | +$191K | 0.1% | 116 |
|
|
2023
Q3 | $145K | Hold |
540
| – | – | 0.05% | 151 |
|
|
2023
Q2 | $125K | Hold |
540
| – | – | 0.04% | 164 |
|
|
2023
Q1 | $131K | Sell |
540
-14
| -3% | -$3.44K | 0.04% | 164 |
|
|
2022
Q4 | $146K | Hold |
554
| – | – | 0.05% | 160 |
|
|
2022
Q3 | $125K | Buy |
554
+284
| +105% | +$68.8K | 0.04% | 162 |
|
|
2022
Q2 | $66K | Hold |
270
| – | – | 0.05% | 114 |
|
|
2022
Q1 | $65K | Hold |
270
| – | – | 0.04% | 119 |
|
|
2021
Q4 | $61K | Hold |
270
| – | – | 0.04% | 127 |
|
|
2021
Q3 | $57K | Hold |
270
| – | – | 0.04% | 130 |
|
|
2021
Q2 | $66K | Buy |
+270
| New | +$66.4K | 0.04% | 112 |
|
|
2021
Q1 | – | Sell |
-289
| Closed | -$66K | – | 101 |
|
|
2020
Q4 | $66K | Hold |
289
| – | – | 0.04% | 124 |
|
|
2020
Q3 | $73K | Buy |
289
+19
| +7% | +$4.71K | 0.06% | 110 |
|
|
2020
Q2 | $64K | Hold |
270
| – | – | 0.05% | 114 |
|
|
2020
Q1 | $55K | Hold |
270
| – | – | 0.05% | 126 |
|
|
2019
Q4 | $65K | Hold |
270
| – | – | 0.05% | 130 |
|
|
2019
Q3 | $52K | Hold |
270
| – | – | 0.04% | 130 |
|
|
2019
Q2 | $50K | Hold |
270
| – | – | 0.04% | 129 |
|
|
2019
Q1 | $52K | Hold |
270
| – | – | 0.04% | 128 |
|
|
2018
Q4 | $53K | Hold |
270
| – | – | 0.05% | 140 |
|
|
2018
Q3 | $56K | Hold |
270
| – | – | 0.04% | 130 |
|
|
2018
Q2 | $50K | Buy |
+270
| New | +$47.8K | 0.04% | 138 |
|
|
2018
Q1 | – | Sell |
-850
| Closed | -$148K | – | 120 |
|
|
2017
Q4 | $148K | Hold |
850
| – | – | 0.1% | 116 |
|
|
2017
Q3 | $158K | Hold |
850
| – | – | 0.12% | 117 |
|
|
2017
Q2 | $146K | Buy |
+850
| New | +$138K | 0.12% | 108 |
|
Other funds holding AMGN
VCM
VPM
Clearstead Trust's AMGN Position: Q1 2026 in Review
Clearstead Trust reduced its Amgen (AMGN) stake by 19% in Q1 2026, selling an estimated $25K and leaving 305 shares worth $107K. The position accounts for 0.02% of the portfolio, ranked #239.
Clearstead Trust first reported a position in AMGN in Q2 2017 and has held it in 34 quarters since. The position peaked at $357K in Q4 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Clearstead Trust held 305 shares of Amgen worth $107K as of Q1 2026.
- Clearstead Trust sold 70 Amgen shares in Q1 2026, an estimated $25K.
- Amgen made up 0.02% of Clearstead Trust's portfolio in Q1 2026, its #239 holding.
- Clearstead Trust first reported a position in Amgen in Q2 2017 and has held it in 34 quarters since.
- Clearstead Trust's Amgen position peaked at $357K in Q4 2023.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.